Indeed, analyses of circulating tumor cells revealed high levels of chromosomal instability in ALK-positive NSCLC patients that were resistant to ALK inhibitor treatment, and it will be interesting to determine whether this correlates with the EML4-ALK variant expressed (35). The gene discussed is ALK; the disease is non-small cell lung carcinoma.